| 摘要 |
The invention relates to inhalation powder formulations containing enantiomerically pure beta-agonists of formula (1), wherein the radicals R<1>, R<2>, R<3> and R<4 >are defined as in claims and descriptions and are optionally embodied in the form the pharmaceutically acceptable acid addition salts thereof and are optionally combined with a pharmaceutically acceptable accessory agent. A method for producing said formulations and the use thereof in the form of a drug, in particular as a drug for treating respiratory tract diseases are also disclosed. |
